BD (Becton, Dickinson and Company), a global medical technology company, announced the appointment of Dr. Joanne Waldstreicher to its board of directors. Waldstreicher, 63, was most recently the chief medical officer for Johnson & Johnson (J&J), serving in this capacity from 2012 until her retirement in 2023. As chief medical officer, she provided visionary strategic and operational…
BD (Becton, Dickinson and Company), a global medical technology company, announced that Rishi Grover has been named executive vice president (EVP) and chief integrated supply chain officer for BD, effective July 7, 2022. In this role, Grover will have global responsibility for the leadership of the Supply Chain, Operations, Procurement, Sustainability, and Environmental, Health and Safety (EHS) teams…
BD (Becton, Dickinson and Company), a global medical technology company, announced that Shana Neal has been appointed chief people officer, effective April 4, 2022. Neal, who held HR leadership positions at BD from 2005 to 2018, will oversee BD’s Human Resources, Communications and Social Investing functions globally, including Talent Acquisition and Management; Total Rewards; HR Operations; HR Business…
Medical tech giant BD (Becton, Dickinson and Company) announced the appointment of Dr. Carrie L. Byington to the company’s board of directors. Byington, 58, is executive vice president and head of University of California Health (UCH), where she leads the largest academic health system in the U.S. UCH’s six academic health centers and 20 health professional schools form a…